Stefan Sven Marcel, Rafehi Muhammad
Medicinal Chemistry and Systems Polypharmacology, Medical Systems Biology Division, Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck and University Medical Center Schleswig-Holstein (UKSH), Lübeck, Germany.
Department of Biopharmacy, Medical University of Lublin, Lublin, Poland.
Front Pharmacol. 2024 Jul 18;15:1419110. doi: 10.3389/fphar.2024.1419110. eCollection 2024.
Medicinal polypharmacology is one answer to the complex reality of multifactorial human diseases that are often unresponsive to single-targeted treatment. It is an admittance that intrinsic feedback mechanisms, crosstalk, and disease networks necessitate drugs with broad modes-of-action and multitarget affinities. Medicinal polypharmacology grew to be an independent research field within the last two decades and stretches from basic drug development to clinical research. It has developed its own terminology embedded in general terms of pharmaceutical drug discovery and development at the intersection of medicinal chemistry, chemical biology, and clinical pharmacology. A clear and precise language of critical terms and a thorough understanding of underlying concepts is imperative; however, no comprehensive work exists to this date that could support researchers in this and adjacent research fields. In order to explore novel options, establish interdisciplinary collaborations, and generate high-quality research outputs, the present work provides a first-in-field glossary to clarify the numerous terms that have originated from various individual disciplines.
药物多药理学是解决多因素人类疾病复杂现实的一种方法,这些疾病往往对单一靶点治疗无反应。这承认了内在反馈机制、相互作用和疾病网络需要具有广泛作用模式和多靶点亲和力的药物。在过去二十年中,药物多药理学发展成为一个独立的研究领域,涵盖从基础药物开发到临床研究。它在药物化学、化学生物学和临床药理学的交叉点上,形成了自己嵌入药物发现和开发通用术语中的术语体系。关键术语需要清晰准确的语言表达以及对基础概念的透彻理解;然而,迄今为止,尚无全面的著作能支持该领域及相邻研究领域的研究人员。为了探索新的选择、建立跨学科合作并产生高质量的研究成果,本研究提供了该领域的首个术语表,以澄清源自各个学科的众多术语。